{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:05:13Z","timestamp":1791389113807,"version":"4.3.3"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011057","name":"National Center for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.virol.2023.109883","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T04:39:28Z","timestamp":1694752768000},"page":"109883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Activity of domain III-specific antibodies in early convalescence: A case study"],"prefix":"10.1016","volume":"587","author":[{"given":"Danya","family":"Medina-Carrasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Pupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis G.","family":"Gonz\u00e1lez-Lodeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisandra E.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6731-1757","authenticated-orcid":false,"given":"Vivian","family":"Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.virol.2023.109883_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2023.109883_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-7-129","article-title":"Evaluation of immunoglobulin purification methods and their impact on quality and yield of antigen-specific antibodies","volume":"7","author":"Bergmann-Leitner","year":"2008","journal-title":"Malar. J."},{"issue":"7446","key":"10.1016\/j.virol.2023.109883_bib3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.virol.2023.109883_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jmv.1890230209","article-title":"Detection of flavivirus antibodies in human serum by epitope\u2010blocking immunoassay","volume":"23","author":"Burke","year":"1987","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.virol.2023.109883_bib5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4269\/ajtmh.1988.38.172","article-title":"A prospective study of dengue infections in Bangkok","volume":"38","author":"Burke","year":"1988","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.virol.2023.109883_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.apjtm.2016.12.002","article-title":"Serodiagnosis of asymptomatic dengue infection","volume":"10","author":"Chatchen","year":"2017","journal-title":"Asian Pac. J. Tropical Med."},{"issue":"2","key":"10.1016\/j.virol.2023.109883_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005395","article-title":"Dengue virus antibody database: systematically linking serotype-specificity with epitope mapping in dengue virus","volume":"11","author":"Chaudhury","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"16","key":"10.1016\/j.virol.2023.109883_bib8","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","article-title":"Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells","volume":"75","author":"Crill","year":"2001","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.virol.2023.109883_bib9","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions","volume":"109","author":"De Alwis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.virol.2023.109883_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2023.109883_bib11","series-title":"Longitudinal Analysis of Acute and Convalescent B Cell Responses in a Human Primary Dengue Serotype 2 Infection Model","author":"Emerling","year":"2019"},{"issue":"3","key":"10.1016\/j.virol.2023.109883_bib12","doi-asserted-by":"crossref","first-page":"e975","DOI":"10.1371\/journal.pntd.0000975","article-title":"Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand","volume":"5","author":"Endy","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virol.2023.109883_bib13","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s00253-018-8822-y","article-title":"Dengue viruses and promising envelope protein domain III-based vaccines","volume":"102","author":"Fahimi","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.virol.2023.109883_bib14","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1038\/ncomms7341","article-title":"A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins","volume":"6","author":"Fibriansah","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.virol.2023.109883_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-11-34","article-title":"Dengue-2 structural proteins associate with human proteins to produce a coagulation and innate immune response biased interactome","volume":"11","author":"Folly","year":"2011","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.virol.2023.109883_bib16","volume":"vol. 261","author":"Fu","year":"2008"},{"issue":"1","key":"10.1016\/j.virol.2023.109883_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3343\/alm.2022.42.1.3","article-title":"Hormone immunoassay interference: a 2021 update","volume":"42","author":"Ghazal","year":"2022","journal-title":"Annals of laboratory medicine"},{"key":"10.1016\/j.virol.2023.109883_bib18","series-title":"New Treatment Strategies for Dengue and Other Flaviviral Diseases: Novartis Foundation Symposium 277","article-title":"Dengue\/dengue haemorrhagic fever: history and current status","author":"Gubler","year":"2006"},{"issue":"5","key":"10.1016\/j.virol.2023.109883_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00001432-200210000-00003","article-title":"Dengue","volume":"15","author":"Halstead","year":"2002","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.virol.2023.109883_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jmv.1890450417","article-title":"Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2","volume":"45","author":"He","year":"1995","journal-title":"J. Med. Virol."},{"issue":"4Suppl. MENT","key":"10.1016\/j.virol.2023.109883_bib21","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.2149\/tmh.2011-S03","article-title":"Dengue virus receptor","volume":"39","author":"Hidari","year":"2011","journal-title":"Trop. Med. Health"},{"issue":"1","key":"10.1016\/j.virol.2023.109883_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1567-1348(03)00004-2","article-title":"The origin, emergence and evolutionary genetics of dengue virus","volume":"3","author":"Holmes","year":"2003","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.virol.2023.109883_bib27","unstructured":"Huerta Galindo, V., et al., 2007. Methods for the treatment of flavivirus infection, molecules and uses thereof."},{"issue":"12","key":"10.1016\/j.virol.2023.109883_bib23","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1099\/vir.0.068544-0","article-title":"Receptor-activated human \u03b12-macroglobulin interacts with the envelope protein of dengue virus and protects virions from temperature-induced inactivation through multivalent binding","volume":"95","author":"Huerta","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2023.109883_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jprot.2015.11.003","article-title":"Novel interactions of domain III from the envelope glycoprotein of dengue 2 virus with human plasma proteins","volume":"131","author":"Huerta","year":"2016","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.virol.2023.109883_bib25","first-page":"2020","article-title":"The low-density lipoprotein receptor-related protein-1 is essential for Dengue virus infection","author":"Huerta","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.virol.2023.109883_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-0716-1879-0_10","article-title":"Isolation and identification of dengue virus interactome with human plasma proteins by affinity purification-mass spectrometry","author":"Huerta","year":"2022","journal-title":"Dengue Virus: Methods and Protocols"},{"issue":"44","key":"10.1016\/j.virol.2023.109883_bib28","doi-asserted-by":"crossref","first-page":"18950","DOI":"10.1073\/pnas.1011036107","article-title":"Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354","volume":"107","author":"Kaufmann","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.virol.2023.109883_bib29","article-title":"Dengue hemorrhagic fever in Cuba, 1981: rapid diagnosis of the etiologic agent","volume":"17","author":"Kouri","year":"1983","journal-title":"Bull. Pan Am. Health Organ."},{"issue":"42","key":"10.1016\/j.virol.2023.109883_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg4084","article-title":"Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies","volume":"7","author":"Kudlacek","year":"2021","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.virol.2023.109883_bib31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.virol.2023.109883_bib32","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.3389\/fimmu.2018.02180","article-title":"Flavivirus receptors: diversity, identity, and cell entry","volume":"9","author":"Laureti","year":"2018","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.virol.2023.109883_bib33","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1128\/JCM.40.11.4317-4320.2002","article-title":"Serological differentiation of infections with dengue virus serotypes 1 to 4 by using recombinant antigens","volume":"40","author":"Ludolfs","year":"2002","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.virol.2023.109883_bib34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jcv.2009.03.016","article-title":"Highly specific detection of antibodies to tick-borne encephalitis (TBE) virus in humans using a domain III antigen and a sensitive immune complex (IC) ELISA","volume":"45","author":"Ludolfs","year":"2009","journal-title":"J. Clin. Virol."},{"issue":"12","key":"10.1016\/j.virol.2023.109883_bib35","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.virol.2023.109883_bib36","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/JVI.79.2.1223-1231.2005","article-title":"Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein","volume":"79","author":"Modis","year":"2005","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2023.109883_bib37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.biotechadv.2010.11.008","article-title":"Review of dengue virus and the development of a vaccine","volume":"29","author":"Murrell","year":"2011","journal-title":"Biotechnol. Adv."},{"issue":"9","key":"10.1016\/j.virol.2023.109883_bib38","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3390\/v4091731","article-title":"Neutralization interfering antibodies: a \u201cnovel\u201d example of humoral immune dysfunction facilitating viral escape?","volume":"4","author":"Nicasio","year":"2012","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.virol.2023.109883_bib39","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1038\/s41467-022-33336-3","article-title":"Neutralizing and interfering human antibodies define the structural and mechanistic basis for antigenic diversion","volume":"13","author":"Patel","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.virol.2023.109883_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1762465","article-title":"Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB\/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule","volume":"9","author":"Popa","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.virol.2023.109883_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jprot.2017.07.004","article-title":"An \u201con-matrix\u201d digestion procedure for AP-MS experiments dissects the interplay between complex-conserved and serotype-specific reactivities in Dengue virus-human plasma interactome","volume":"193","author":"Ramos","year":"2019","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.virol.2023.109883_bib42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s40475-013-0002-7","article-title":"Dengue virus cellular receptors and tropism","volume":"1","author":"Reyes-del Valle","year":"2014","journal-title":"Current Tropical Medicine Reports"},{"issue":"2","key":"10.1016\/j.virol.2023.109883_bib43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0042-6822(90)90102-W","article-title":"Molecular evolution and distribution of dengue viruses type 1 and 2 in nature","volume":"174","author":"Rico-Hesse","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.virol.2023.109883_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-3527(03)59005-4","article-title":"Antigenic structure of flavivirus proteins","volume":"59","author":"Roehrig","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.virol.2023.109883_bib45","series-title":"Beta Hairpin Peptides Having Antiviral Properties against Dengue Virus","author":"Santiago","year":"2018"},{"issue":"1","key":"10.1016\/j.virol.2023.109883_bib46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0022-1759(90)90242-N","article-title":"Analysis of glycosylation changes in IgG using lectins","volume":"131","author":"Sumar","year":"1990","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.virol.2023.109883_bib47","first-page":"105","article-title":"Interferences in immunoassay","volume":"25","author":"Tate","year":"2004","journal-title":"Clin. Biochem. Rev."},{"issue":"6","key":"10.1016\/j.virol.2023.109883_bib48","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/irv.12591","article-title":"Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses","volume":"12","author":"Trombetta","year":"2018","journal-title":"Influenza and Other Respiratory Viruses"},{"issue":"1","key":"10.1016\/j.virol.2023.109883_bib49","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1038\/s41598-018-24003-z","article-title":"ENSO-driven climate variability promotes periodic major outbreaks of dengue in Venezuela","volume":"8","author":"Vincenti-Gonzalez","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.virol.2023.109883_bib50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virol.2009.06.037","article-title":"Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody","volume":"392","author":"Wahala","year":"2009","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.virol.2023.109883_bib51","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/v3122374","article-title":"The human antibody response to dengue virus infection","volume":"3","author":"Wahala","year":"2011","journal-title":"Viruses"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223002027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682223002027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:07:38Z","timestamp":1727741258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682223002027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":51,"alternative-id":["S0042682223002027"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2023.109883","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of domain III-specific antibodies in early convalescence: A case study","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2023.109883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109883"}}